Molecule Holdings Inc. (EVRRF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.09 Million | -2.4 Million | -689.03 Thousand | -677.9 Thousand | -75.49 Thousand | -501.29 Thousand |
| Net Income | -3.33 Million | -3.41 Million | -2.49 Million | -830.25 Thousand | -263.48 Thousand | -8.3 Million |
| Depreciation & Amortization | 29.17 Thousand | 163.45 Thousand | 35.98 Thousand | 21.29 Thousand | - | - |
| Deferred income taxes | 870.95 Thousand | -2.06 Million | -395.98 Thousand | -432.57 Thousand | - | - |
| Stock-based compensation | 71.74 Thousand | 1.05 Million | 392.5 Thousand | 157.47 Thousand | - | - |
| Change in working capital | 1.26 Million | -953.9 Thousand | 347.12 Thousand | 1634.27 | 108.79 Thousand | -96.53 Thousand |
| Other non-cash items | 11.32 Thousand | 2.8 Million | 1.42 Million | 404.53 Thousand | 78.94 Thousand | 7.87 Million |
| Investing Cash Flow | -24.29 Thousand | 134.69 Thousand | -954.58 Thousand | -1.43 Million | -129.09 Thousand | -382.23 Thousand |
| Investments in PPE | -24.29 Thousand | -62.03 Thousand | -1.42 Million | -1.2 Million | -135.86 Thousand | -385.18 Thousand |
| Acquisitions | - | 62.14 Thousand | 203.5 Thousand | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | 134.58 Thousand | 35.29 Thousand | - | - | 2957.10 |
| Other Investing Activities | 3411.00 | - | 230.3 Thousand | -233.63 Thousand | 6770.23 | - |
| Financing Cash Flow | 293.01 Thousand | 2.51 Million | 604.38 Thousand | 3.85 Million | 82.23 Thousand | 805.87 Thousand |
| Debt repayment | -339.23 Thousand | -2.54 Million | -619.38 Thousand | -40 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 3.88 Million | - | 805.87 Thousand |
| Other Financing Activities | 632.24 Thousand | 5.06 Million | 1.22 Million | 9567.00 | 82.23 Thousand | - |
| Accounts receivables | 79.06 Thousand | -232.53 Thousand | 177.49 Thousand | -232.51 Thousand | 254.33 | 25.59 Thousand |
| Accounts payables | 1.13 Million | 9383.34 | - | - | - | - |
| Inventory | -216.11 Thousand | -459.13 Thousand | -109.01 Thousand | - | - | - |
| Other working capital | 259.72 Thousand | -271.62 Thousand | 278.64 Thousand | 234.15 Thousand | 108.53 Thousand | -122.12 Thousand |
| Cash at beginning of period | 143.92 Thousand | 676.88 Thousand | 1.74 Million | 8691.41 | 133.5 Thousand | 203.09 Thousand |
| Cash at end of period | 61.35 Thousand | 143.92 Thousand | 676.88 Thousand | 1.74 Million | 8691.41 | 133.5 Thousand |
| Capital Expenditure | -24.29 Thousand | -62.03 Thousand | -1.42 Million | -1.2 Million | -135.86 Thousand | -385.18 Thousand |
| Effect of forex changes on cash | -1.73 | -0.10 | -1.01 | -0.74 | - | - |
| Net cash flow / Change in cash | -82.56 Thousand | -532.95 Thousand | -1.06 Million | 1.73 Million | -124.8 Thousand | -69.59 Thousand |
| Free Cash Flow | -1.11 Million | -2.46 Million | -2.11 Million | -1.88 Million | -211.36 Thousand | -886.48 Thousand |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -596.42 Thousand | -477.15 Thousand | -511.73 Thousand | -3.33 Million | -1.06 Million | -581.61 Thousand |
| Depreciation & Amortization | 33.09 Thousand | 7273.97 | 7405.09 | 29.17 Thousand | 7234.53 | 8001.59 |
| Deferred income taxes | - | - | 117.99 Thousand | 870.95 Thousand | 731.29 Thousand | - |
| Stock-based compensation | 8422.82 | 7931.26 | 47.57 Thousand | 71.74 Thousand | -174.94 Thousand | 30.06 Thousand |
| Change in working capital | 375.92 Thousand | 19.71 Thousand | 249.55 Thousand | 1.26 Million | 686.09 Thousand | 204.02 Thousand |
| Other non-cash items | 182.21 Thousand | 375.45 Thousand | 38.63 Thousand | 11.32 Thousand | -169.98 Thousand | 48.63 Thousand |
| Investing Cash Flow | 780.00 | 73.78 Thousand | - | -24.29 Thousand | -0.73 | 1998.83 |
| Investments in PPE | 0.76 | - | - | -24.29 Thousand | -0.73 | 1998.83 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | 73.78 Thousand | - | - | - | - |
| Other Investing Activities | 591.55 | 74.24 Thousand | - | - | 234.90 | - |
| Financing Cash Flow | -177.43 Thousand | 172.63 Thousand | -11.82 Thousand | 293.01 Thousand | -6258.58 | 147.88 Thousand |
| Debt repayment | -189.47 Thousand | -184.45 Thousand | -15.75 Thousand | -339.23 Thousand | -5298.77 | -160.19 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 12.03 Thousand | 357.08 Thousand | 3921.00 | 632.24 Thousand | -959.81 | 49.89 Thousand |
| Accounts receivables | -248.32 Thousand | 208.19 Thousand | -16.09 Thousand | 79.06 Thousand | 311.34 Thousand | -214.71 Thousand |
| Accounts payables | 190.16 Thousand | -55.99 Thousand | 202.07 Thousand | 1.13 Million | 458.78 Thousand | 344.49 Thousand |
| Inventory | 601.43 Thousand | -306.43 Thousand | -5603.21 | -216.11 Thousand | -199.31 Thousand | 78.35 Thousand |
| Other working capital | -415.68 Thousand | 382.14 Thousand | 69.17 Thousand | 259.72 Thousand | 115.27 Thousand | -4101.00 |
| Cash at beginning of period | 172.09 Thousand | 400.34 | 61.35 Thousand | 143.92 Thousand | 57.21 Thousand | 227.16 Thousand |
| Cash at end of period | 107.56 Thousand | 172.09 Thousand | 400.34 | 61.35 Thousand | 61.35 Thousand | 57.21 Thousand |
| Capital Expenditure | 0.76 | - | - | -24.29 Thousand | -0.73 | 1998.83 |
| Effect of forex changes on cash | -780.03 | -0.82 | - | -1.73 | 0.42 | 1111.17 |
| Net cash flow / Change in cash | -64.52 Thousand | 171.69 Thousand | -60.95 Thousand | -82.56 Thousand | 4140.00 | -169.94 Thousand |
| Free Cash Flow | -5184.04 | -74.71 Thousand | -50.57 Thousand | -1.11 Million | 13.86 Thousand | -318.94 Thousand |
KITEX
MGA
GSLSEC
GLSTW
CCPUF
CHXMF